These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8368291)

  • 1. Increased clearance of 1,25(OH)2D3 and tissue-specific responsiveness to 1,25(OH)2D3 in diabetic rats.
    Verhaeghe J; Suiker AM; Van Bree R; Van Herck E; Jans I; Visser WJ; Thomasset M; Allewaert K; Bouillon R
    Am J Physiol; 1993 Aug; 265(2 Pt 1):E215-23. PubMed ID: 8368291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral homeostasis in spontaneously diabetic BB rats. I. Abnormal vitamin D metabolism and impaired active intestinal calcium absorption.
    Nyomba BL; Verhaeghe J; Thomasset M; Lissens W; Bouillon R
    Endocrinology; 1989 Feb; 124(2):565-72. PubMed ID: 2536313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25(OH)2D3 and Ca-binding protein in fetal rats: relationship to the maternal vitamin D status.
    Verhaeghe J; Thomasset M; Bréhier A; Van Assche FA; Bouillon R
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E505-12. PubMed ID: 3354665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
    Safadi FF; Hermey DC; Popoff SN; Seifert MF
    Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
    Gunness-Hey M; Hock JM; Gera I; Fonseca J; Poser J; Bevan J; Raisz LG
    Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization.
    Wronski TJ; Halloran BP; Bikle DD; Globus RK; Morey-Holton ER
    Endocrinology; 1986 Dec; 119(6):2580-5. PubMed ID: 3780540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of in vivo and in vitro insulin on renal 25 (OH) D3 hydroxylation in insulin dependent diabetic rats.
    Weaver VM; Welsh JE
    Diabetes Res; 1994; 25(3):107-19. PubMed ID: 7671550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness of the intestinal 1,25-dihydroxyvitamin D3 receptor to magnesium depletion in the rat.
    Lemay J; Gascon-Barré M
    Endocrinology; 1992 May; 130(5):2767-77. PubMed ID: 1315257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] metabolism in vitamin D-deficient rats infused with 1,25-(OH)2D3.
    Yamato H; Matsumoto T; Fukumoto S; Ikeda K; Ishizuka S; Ogata E
    Endocrinology; 1989 Jan; 124(1):511-7. PubMed ID: 2783309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis.
    Verhaeghe J; Suiker AM; Nyomba BL; Visser WJ; Einhorn TA; Dequeker J; Bouillon R
    Endocrinology; 1989 Feb; 124(2):573-82. PubMed ID: 2643507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats.
    Gunness-Hey M; Gera I; Fonseca J; Raisz LG; Hock JM
    Calcif Tissue Int; 1988 Nov; 43(5):284-8. PubMed ID: 3145794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different responses of trabecular and cortical bone to 1,25(OH)2D3 infusion.
    Bikle DD; Halloran BP; McGalliard-Cone C; Morey-Holton E
    Am J Physiol; 1990 Nov; 259(5 Pt 1):E715-22. PubMed ID: 2240210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary calcium on the response of bone to 1,25 (OH)2D3.
    Boyce RW; Weisbrode SE
    Lab Invest; 1983 Jun; 48(6):683-9. PubMed ID: 6687909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
    Yao J; Kathpalia P; Bushinsky DA; Favus MJ
    J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic bone disease. Low turnover osteoporosis related to decreased IGF-I production.
    Bouillon R
    Verh K Acad Geneeskd Belg; 1992; 54(4):365-91; discussion 391-2. PubMed ID: 1466160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent warfarin treatment further reduces bone mineral levels in 1,25-dihydroxyvitamin D3-treated rats.
    Price PA; Sloper SA
    J Biol Chem; 1983 May; 258(10):6004-7. PubMed ID: 6602126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-calcium diets increase both production and clearance of 1,25-dihydroxyvitamin D3 in rats.
    Fox J; Bunker JE; Kamimura M; Wong PF
    Am J Physiol; 1990 Feb; 258(2 Pt 1):E282-7. PubMed ID: 2154934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and metabolic clearance rates of 1,25-dihydroxyvitamin D3 during maturation in rats: studies using a rapid, primed-infusion technique.
    Fox J
    Horm Metab Res; 1990 May; 22(5):278-82. PubMed ID: 2347542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis.
    Verhaeghe J; van Herck E; Visser WJ; Suiker AM; Thomasset M; Einhorn TA; Faierman E; Bouillon R
    Diabetes; 1990 Apr; 39(4):477-82. PubMed ID: 2180758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 1,25-dihydroxyvitamin D3 on colonic calcium transport in vitamin D-deficient and normal rats.
    Favus MJ; Langman CB
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G268-73. PubMed ID: 6546644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.